Cargando…
MiR-323b-5p acts as a novel diagnostic biomarker for critical limb ischemia in type 2 diabetic patients
Type 2 diabetes mellitus (T2DM) is a major contributor to peripheral artery disease (PAD), especially in cases that advance to critical limb ischemia (CLI). Accumulating evidence indicates that miRNAs play an important role in the development of PAD and T2DM. Due to the limited value of current diag...
Autores principales: | Cheng, Biao, Li, Ju-yi, Li, Xiao-chao, Wang, Xiu-fang, Wang, Zhong-jing, Liu, Jue, Deng, Ai-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179988/ https://www.ncbi.nlm.nih.gov/pubmed/30305681 http://dx.doi.org/10.1038/s41598-018-33310-4 |
Ejemplares similares
-
Circulating MicroRNA-4739 May Be a Potential Biomarker of Critical Limb Ischemia in Patients with Diabetes
por: Li, Ju-yi, et al.
Publicado: (2018) -
Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes
por: Li, Ju-yi, et al.
Publicado: (2017) -
The Diagnostic Classification of Critical Limb Ischemia
por: Azuma, Nobuyoshi
Publicado: (2018) -
Plasma miR-323 as a Biomarker for Screening Papillary Thyroid Cancer From Healthy Controls
por: Liu, Yang, et al.
Publicado: (2020) -
MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome
por: Men, Yu, et al.
Publicado: (2022)